FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012137346> ?p ?o ?g. }

• W2012137346 endingPage "184" @default.
• W2012137346 startingPage "177" @default.
• W2012137346 abstract "Human 15-lipoxygenase-1 (15-LO-1) is an oxidizing enzyme capable of producing reactive lipid hydroperoxides. 15-LO-1 and its products have been suggested to be involved in many pathological conditions, such as inflammation, atherogenesis, and carcinogenesis. We used adenovirus-mediated gene transfers to study the effects of 15-LO-1 on vascular endothelial growth factor (VEGF)-A165- and placental growth factor (PlGF)-induced angiogenesis in rabbit skeletal muscles. 15-LO-1 significantly decreased all angiogenic effects induced by these growth factors, including capillary perfusion, vascular permeability, vasodilatation, and an increase in capillary number. The effects are attributable to the reduction in the amount of VEGF-A165 and PlGF transcripts by 15-LO-1, resulting in reduced protein expression. The most likely mediator of the VEGF family-induced capillary vasodilatation is nitric oxide (NO), which is produced by NO synthases. Endothelial NO synthase protein expression and NO synthase activity were significantly induced by VEGF-A165, and these inductions were reduced by 15-LO-1. VEGF-A165 induces its angiogenic effects primarily via vascular endothelial growth factor receptor (VEGFR)2, and also PlGF mediates angiogenic signaling via VEGFR2, even though it binds to VEGFR1. VEGFR2 expression is induced by peroxisome proliferator-activating receptor . We showed by quantitative RT-PCR and immunohistochemistry that expression of endogenous rabbit peroxisome proliferator-activating receptor and VEGFR2 were significantly increased in the growth factor-transduced muscles, but these inductions were efficiently prevented by 15-LO-1. In conclusion, the results suggest that expression of 15-LO-1 has an efficient antiangiogenic effect in vivo via reduction in growth factor mRNA levels, NO bioactivity, and VEGFR2 expression." @default.
• W2012137346 created "2016-06-24" @default.
• W2012137346 creator A5002292292 @default.
• W2012137346 creator A5009805595 @default.
• W2012137346 creator A5014220812 @default.
• W2012137346 creator A5019229471 @default.
• W2012137346 creator A5044312406 @default.
• W2012137346 creator A5046873939 @default.
• W2012137346 creator A5049789951 @default.
• W2012137346 creator A5056494907 @default.
• W2012137346 creator A5080760539 @default.
• W2012137346 creator A5086532155 @default.
• W2012137346 creator A5014661853 @default.
• W2012137346 date "2008-02-01" @default.
• W2012137346 modified "2023-10-17" @default.
• W2012137346 title "15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A– and Placental Growth Factor–Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression" @default.
• W2012137346 cites W1511385771 @default.
• W2012137346 cites W1606925436 @default.
• W2012137346 cites W1964005024 @default.
• W2012137346 cites W1968719918 @default.
• W2012137346 cites W1972584214 @default.
• W2012137346 cites W1975608072 @default.
• W2012137346 cites W1985517047 @default.
• W2012137346 cites W1988097332 @default.
• W2012137346 cites W1992895170 @default.
• W2012137346 cites W1993383276 @default.
• W2012137346 cites W2002528642 @default.
• W2012137346 cites W2006340844 @default.
• W2012137346 cites W2006384611 @default.
• W2012137346 cites W2011879352 @default.
• W2012137346 cites W2020981164 @default.
• W2012137346 cites W2021241491 @default.
• W2012137346 cites W202235794 @default.
• W2012137346 cites W2028987088 @default.
• W2012137346 cites W2037577105 @default.
• W2012137346 cites W2038545399 @default.
• W2012137346 cites W2043956489 @default.
• W2012137346 cites W2044296969 @default.
• W2012137346 cites W2046122656 @default.
• W2012137346 cites W2057379707 @default.
• W2012137346 cites W2057614949 @default.
• W2012137346 cites W2066312315 @default.
• W2012137346 cites W2066993893 @default.
• W2012137346 cites W2071976338 @default.
• W2012137346 cites W2082884613 @default.
• W2012137346 cites W2083937209 @default.
• W2012137346 cites W2087647782 @default.
• W2012137346 cites W2087933507 @default.
• W2012137346 cites W2092145002 @default.
• W2012137346 cites W2098814720 @default.
• W2012137346 cites W2110603899 @default.
• W2012137346 cites W2129321695 @default.
• W2012137346 cites W2133164252 @default.
• W2012137346 cites W2134563904 @default.
• W2012137346 cites W2134750165 @default.
• W2012137346 cites W2137144410 @default.
• W2012137346 cites W2140857987 @default.
• W2012137346 cites W2149158668 @default.
• W2012137346 cites W2149749420 @default.
• W2012137346 cites W2163069245 @default.
• W2012137346 cites W2166630455 @default.
• W2012137346 cites W2170194456 @default.
• W2012137346 cites W2174848253 @default.
• W2012137346 cites W2185990021 @default.
• W2012137346 cites W2316918019 @default.
• W2012137346 cites W4240908764 @default.
• W2012137346 doi "https://doi.org/10.1161/circresaha.107.155556" @default.
• W2012137346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17991885" @default.
• W2012137346 hasPublicationYear "2008" @default.
• W2012137346 type Work @default.
• W2012137346 sameAs 2012137346 @default.
• W2012137346 citedByCount "50" @default.
• W2012137346 countsByYear W20121373462012 @default.
• W2012137346 countsByYear W20121373462013 @default.
• W2012137346 countsByYear W20121373462014 @default.
• W2012137346 countsByYear W20121373462017 @default.
• W2012137346 countsByYear W20121373462018 @default.
• W2012137346 countsByYear W20121373462019 @default.
• W2012137346 countsByYear W20121373462020 @default.
• W2012137346 countsByYear W20121373462021 @default.
• W2012137346 countsByYear W20121373462022 @default.
• W2012137346 crossrefType "journal-article" @default.
• W2012137346 hasAuthorship W2012137346A5002292292 @default.
• W2012137346 hasAuthorship W2012137346A5009805595 @default.
• W2012137346 hasAuthorship W2012137346A5014220812 @default.
• W2012137346 hasAuthorship W2012137346A5014661853 @default.
• W2012137346 hasAuthorship W2012137346A5019229471 @default.
• W2012137346 hasAuthorship W2012137346A5044312406 @default.
• W2012137346 hasAuthorship W2012137346A5046873939 @default.
• W2012137346 hasAuthorship W2012137346A5049789951 @default.
• W2012137346 hasAuthorship W2012137346A5056494907 @default.
• W2012137346 hasAuthorship W2012137346A5080760539 @default.
• W2012137346 hasAuthorship W2012137346A5086532155 @default.
• W2012137346 hasBestOaLocation W20121373461 @default.
• W2012137346 hasConcept C103041312 @default.
• W2012137346 hasConcept C113045295 @default.
• W2012137346 hasConcept C126322002 @default.
• W2012137346 hasConcept C134018914 @default.

• next